|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This site is Private and is used only for training new Angel Editors, Bloggers & Columnists! | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
1/29/14
The following information is a brief summary of an online article that can be read in full at: http://www.bizjournals.com/sanfrancisco/blog/biotech/2014/01/multiple-sclerosis-ms-myelin-repair-mrf.html
A new way: Foundation lines up generic heart drug for multiple sclerosis trial
A generic high blood pressure drug could be a new treatment for Multiple Sclerosis Patients. This study is being "championed" by a Bay Area nonprofit organization.
There will soon be a Phase I study of the drug being launched by the Myelin Repair Foundation of Saratoga.
There are also concerns that the use of this medication will not be approved in the US (even with a prescription). However, if the makers "tweak" the formula of the drug and get patents for it to treat MS, the company may be able to charge an amount that will cover clinical trial costs.
|
Post a Comment